Select Page

EPHA 2018 Universal Access and Affordable Medicines Forum

TRAILBLAZERS

ROUTES TO BETTER AND AFFORDABLE MEDICINES BY 2025

What do we want from our future medicines policy?

20 November 2018 • Scotland House, Brussels

The 2018 Universal Access and Affordable Medicines Forum comes at a critical juncture for pharmaceutical policy in Europe.

Join the Trailblazers in the European access to medicines debate on 20 November to take stock of recent unprecedented political developments  and to discuss policy recommendations for the next European Commission and Member States’ priorities in terms of medicines policy.

  • Get updated on major political developments and their relevance for the access to medicines debate

  • Understand where the innovation ecosystem is headed towards

  • Enrich your understanding of public investment in medical R&D in Europe

  • Gain insight into key stakeholders’ upcoming health agendas

Programme
09:00-09:30

REGISTRATION AND COFFEE


09:30-09:45

WELCOME AND INTRODUCTION


09:45-11:15

ACCESS TO MEDICINES IN EUROPE: ARE PAYERS FACING A DEAD END?


11:15-11:30

COFFEE BREAK


11:30-13:00

THOUGHT LEADERS FORUM: WHERE DO WE STAND AND WHERE IS MEDICINES POLICY IN EUROPE HEADING?


13:00-14:00

LUNCH


14:00-15:30

PUBLIC INVESTMENT IN MEDICAL R&D IN EUROPE: WHY, WHEN, HOW & WHO?


15:30-15:45

COFFEE BREAK


15:45-17:15

THE INNOVATION ECOSYSTEM IN EUROPE: HOW WILL IT LOOK LIKE IN 2025?


17:15-18:00

NETWORKING RECEPTION

Speakers

Yannis Natsis, Policy Manager for Universal Access and Affordable Medicine, European Public Health Alliance (EPHA)


Jo De Cock, CEO, National Institute of Health and Disability Insurance (RIZIV/INAMI), Belgium


Marjan Suselj, General Director, Health Insurance Institute of Slovenia (HIIS)


Evert Jan van Lente, Director EU-Affairs, AOK-Bundesverband, Germany


Adrian van den Hoven, Director General, Medicines For Europe


Paola Testori Coggi, Italian Medicines Agency (AIFA)


Clemens Auer, Special Envoy for Health, Federal Ministry of Labour, Social Affairs, Health and Consumer Protection, Austria


Carlo Maria Marenghi, Legal Attaché for Intellectual Property and Trade issues, Holy See


Ri De Ridder, President, Médecins du Monde, Belgium


Nathalie Moll, Director General, European Federation of Pharmaceutical Industries and Associations, (EFPIA)


Marie-Paule Kieny, Director of Research, French National Institute of Health and Medical Research (INSERM), France


Stefano Vella, Director, National Center for Global Health, Istituto Superiore di Sanita (ISS), Italy


Stuart Pritchard, Manager, European Union and Public Affairs, Wellcome Trust


Viviana Galli, Coordinator, European Alliance for Responsible R&D and Affordable Medicines


Rufus Pollock, Enterpreneur, Founder & President of Open Knowledge


Jan Van den Bossche, Partner, Fund+, Belgium


Zoltán Kaló, Professor of Health Economics, Eötvös Loránd University (ELTE), Hungary


Carin Uyl-de Groot, Professor of Health Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Netherlands


Moderator: Tania Dussey-Cavassini

Logistics

Contact

Yannis Natsis

Policy Manager for Universal Access and Affordable Medicines

Made with love by COCREATE

SUBSCRIBE TO OUR MAILING LIST

We publish our newsletter ten times a year to keep you informed about the latest news on public health in Europe. You can receive it directly in your mailbox.
First Name
Last Name
Email address
Secure and Spam free...